Abstract
Patients with coronary artery disease (CAD), particularly those with metabolic
disorders, including liver dysfunction, belong to a group at very high risk of developing
cardiovascular events. This literature review provides a detailed analysis of studies examining
the clinical and angiographic indicators in CAD patients with impaired liver function.
